Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Live
Q2 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
08/06/14 at 8:30 a.m. ET
Q2 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
Wednesday, August 6, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
More >>
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe
Investor Downloads

Download Documentation Corporate Presentation
More >>

ARIAD Stock Price: $5.61

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 08/01/14

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Down 0.15 (2.60%)
DAY LOW$5.43
52 WK. HIGH$23.00
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

You are now leaving this website. If you would like to continue, click Continue.